COLUMBUS, Ohio--(BUSINESS WIRE)--June 14, 2006--OptiCell MAX incorporates OptiCell®'s novel design and performance properties in making it the ideal tool for continuous laboratory-scale production of monoclonal antibodies from antibody-expressing hybridoma cell lines.
